--- title: "周五 agilon health 的股票发生了什么情况？" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/285753342.md" description: "Agilon Health Inc. (AGL) 的股价在周五下跌了 11.52%，至 53.67 美元，此前一天股价上涨超过 100%。交易者在强劲的季度财报公布后获利了结，该财报超出了预期。尽管股价下跌，富国银行仍维持了 “增持” 评级，并将价格预测从 37.5 美元上调至 72 美元，理由是对 2026 年的积极指引。Agilon 的销售额达到 14.2 亿美元，超出预期，公司将其 2026 财年的销售前景上调至 56.8 亿至 58.1 亿美元，高于市场共识的 54.5 亿美元" datetime: "2026-05-08T15:59:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285753342.md) - [en](https://longbridge.com/en/news/285753342.md) - [zh-HK](https://longbridge.com/zh-HK/news/285753342.md) --- # 周五 agilon health 的股票发生了什么情况？ **Agilon Health Inc. ( AGL )** shares are trading lower Friday. The move follows a massive Thursday rally where the stock soared over 100%. Traders appear to be taking profits after the company crushed quarterly expectations. The Nasdaq is up 1.75% while the S&P 500 has gained 0.72%. ## Wells Fargo Boosts Price Forecast Despite the Friday dip, analysts remain optimistic about the company’s trajectory. **Wells Fargo** maintained an Overweight rating on Agilon Health ( AGL ). Wells Fargo raised the price forecast from $37.5 to $72. This update followed the company’s upbeat 2026 guidance. ## Profit Taking After Record Gains The stock’s decline on Friday represents a natural correction. Retail traders are likely locking in gains from that surge. The rally was fueled by first-quarter earnings of $1.80 per share. This beat the $1.31 consensus estimate. ## Operational Initiatives Drive Sentiment The analyst focus remains on the company’s Total Care Model. Executive Chairman **Ronald Williams** noted the company is seeing early returns from investments in data and technology. Sales reached $1.42 billion, surpassing Wall Street’s $1.38 billion forecast. ## Agilon Health Raises Outlook Agilon raised its fiscal 2026 sales guidance to a range of $5.68 billion to $5.81 billion. This sits well above the $5.45 billion consensus. While membership decreased to 536,000, medical margins improved to $149 million. ## Agilon Health Price Action **AGL Stock Price Activity:** Agilon Health ( AGL ) shares were down 11.52% at $53.67 at the time of publication on Friday, according to Benzinga Pro data. _Photo by Piotr Swat via Shutterstock_ ### 相关股票 - [AGL.US](https://longbridge.com/zh-CN/quote/AGL.US.md) - [IHF.US](https://longbridge.com/zh-CN/quote/IHF.US.md) - [VHT.US](https://longbridge.com/zh-CN/quote/VHT.US.md) - [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md) - [.IXIC.US](https://longbridge.com/zh-CN/quote/.IXIC.US.md) - [.SPX.US](https://longbridge.com/zh-CN/quote/.SPX.US.md) - [WFC.US](https://longbridge.com/zh-CN/quote/WFC.US.md) - [SSTK.US](https://longbridge.com/zh-CN/quote/SSTK.US.md) - [WFC-D.US](https://longbridge.com/zh-CN/quote/WFC-D.US.md) - [WFC-L.US](https://longbridge.com/zh-CN/quote/WFC-L.US.md) - [WFC-Y.US](https://longbridge.com/zh-CN/quote/WFC-Y.US.md) - [WFC-C.US](https://longbridge.com/zh-CN/quote/WFC-C.US.md) - [WFC-Z.US](https://longbridge.com/zh-CN/quote/WFC-Z.US.md) - [WFC-A.US](https://longbridge.com/zh-CN/quote/WFC-A.US.md) ## 相关资讯与研究 - [agilon health｜8-K：2026 财年 Q1 营收 14.2 亿美元超过预期](https://longbridge.com/zh-CN/news/285430759.md) - [瑞银上调爵士制药评级：核心业务韧性强劲，新药 Ziihera 成增长引擎](https://longbridge.com/zh-CN/news/286920691.md) - [Wolverine 发布 2026 财年 EPS 指引 上调全年利润率预期](https://longbridge.com/zh-CN/news/286456355.md) - [美银大幅上调 2026 年标普 500 盈利预期：Q1 财报 “炸场” 之后，盈利周期仍在扩张](https://longbridge.com/zh-CN/news/286862606.md) - [摩根大通看好戴尔与慧与科技，财报前上调目标价](https://longbridge.com/zh-CN/news/286589228.md)